Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Melanson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2014
Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory taskKelsey Witiuk, Juan Fernandez-Ruiz, Ryan McKee, et al.
Annals of Neurology|June 27, 2009
A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgiaTanya Z Fischer, Elaine S Gilmore, Mark Estacion, et al.
Journal of Neurology|January 25, 2011
Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2Donald S McCorquodale, Gladys Montenegro, Ainsley Peguero, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 16, 2018
Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral SclerosisVictoria L Hodgkinson, Josh Lounsberry, Ario Mirian, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 27, 2021
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practicesKristiana Salmon, Nancy Anoja, Ari Breiner, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 5, 2020
A National Spinal Muscular Atrophy Registry for Real-World EvidenceVictoria L Hodgkinson, Maryam Oskoui, Joshua Lounsberry, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2014
Cognitive deterioration and functional compensation in ALS measured with fMRI using an inhibitory taskKelsey Witiuk, Juan Fernandez-Ruiz, Ryan McKee, et al.
Annals of Neurology|June 27, 2009
A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgiaTanya Z Fischer, Elaine S Gilmore, Mark Estacion, et al.
Journal of Neurology|January 25, 2011
Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2Donald S McCorquodale, Gladys Montenegro, Ainsley Peguero, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 16, 2018
Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral SclerosisVictoria L Hodgkinson, Josh Lounsberry, Ario Mirian, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 27, 2021
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practicesKristiana Salmon, Nancy Anoja, Ari Breiner, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
The CNDR: collaborating to translate new therapies for CanadiansLawrence Korngut, Craig Campbell, Megan Johnston, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 5, 2020
A National Spinal Muscular Atrophy Registry for Real-World EvidenceVictoria L Hodgkinson, Maryam Oskoui, Joshua Lounsberry, et al.
Pageof 2